Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Published Online
on June 12, 2008

Arteriosclerosis, Thrombosis, and Vascular Biology. 2008
Published online before print June 12, 2008, doi: 10.1161/ATVBAHA.108.162511
A more recent version of this article appeared on September 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
28/9/1640    most recent
ATVBAHA.108.162511v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Armstrong, L.-J.
Right arrow Articles by Bicknell, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Armstrong, L.-J.
Right arrow Articles by Bicknell, R.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Protein
*UniGene
*Genetics Home Reference

Submitted on February 19, 2007
Accepted on June 2, 2008

ECSM2, An Endothelial Specific Filamin A Binding Protein That Mediates Chemotaxis

Laura-Jane Armstrong ; Victoria L. Heath ; Sharon Sanderson ; Sukhbir Kaur ; James F.J. Beesley ; John M.J. Herbert ; John A. Legg ; Richard Poulsom ; and Roy Bicknell *

From the Angiogenesis Laboratory (L.-J.A., S.S., J.M.J.H., R.B.), Cancer Research UK, Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford; Cancer Research UK Angiogenesis Group (V.L.H., S.K., J.F.J.B., J.M.J.H., J.A.L., R.B.), The Institute for Biomedical Research, University of Birmingham Medical School, Edgbaston; and Cancer Research UK (R.P.), The London Research Institute, Lincoln's Inn Fields, London, UK.

* To whom correspondence should be addressed. E-mail: R.Bicknell{at}bham.ac.uk.

Objective—We aimed to characterize the expression and function of a novel transcript that bioinformatics analysis predicted to be endothelial specific, called endothelial-specific molecule-2 (ECSM2).

Methods and Results—A full-length cDNA was isolated and predicted ECSM2 to be a putative 205–amino acid transmembrane protein that bears no homology to any known protein. Quantitative polymerase chain reaction analysis in vitro and in situ hybridization analysis in vivo confirmed ECSM2 expression to be exclusively endothelial, and localization to the plasma membrane was shown. Knockdown of ECSM2 expression in human umbilical vein endothelial cells using siRNA resulted in both reduced chemotaxis and impaired tube formation on matrigel, a solubilized basement membrane, both processes involved in angiogenesis. A yeast 2 hybrid analysis using the ECSM2 intracellular domain identified filamin A, as an interacting protein. This interaction was confirmed by precipitation of filamin-A from endothelial cell lysates by a GST-tagged intracellular domain of ECSM2.

Conclusion—This study is the first to characterize a novel cell surface protein ECSM2 that regulates endothelial chemotaxis and tube formation, and interacts with filamin A. These studies implicate a role for ECSM2 in angiogenesis via modulation of the actin cytoskeleton.


Key words: endothelial genes • transmembrane proteins • filamin • cell signaling • chemotaxis • angiogenesis